Cerebain Biotech Corp is a biomedical company. It acts as a development-stage medical device company which focuses on the creation and clinical development of a minimally invasive implantable device. The company is engaged in the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The Omentum is a layer of tissue lying over internal organs which generate biological agents that nourish nerves and help them grow. The company also focuses on producing both a medical device solution as well as a synthetic drug solution.